3-16270968-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_138381.5(OXNAD1):​c.16G>A​(p.Val6Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

OXNAD1
NM_138381.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.345

Publications

0 publications found
Variant links:
Genes affected
OXNAD1 (HGNC:25128): (oxidoreductase NAD binding domain containing 1) Predicted to enable oxidoreductase activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03772849).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OXNAD1NM_138381.5 linkc.16G>A p.Val6Ile missense_variant Exon 3 of 9 ENST00000285083.10 NP_612390.1 Q96HP4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OXNAD1ENST00000285083.10 linkc.16G>A p.Val6Ile missense_variant Exon 3 of 9 1 NM_138381.5 ENSP00000285083.5 Q96HP4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.16G>A (p.V6I) alteration is located in exon 3 (coding exon 1) of the OXNAD1 gene. This alteration results from a G to A substitution at nucleotide position 16, causing the valine (V) at amino acid position 6 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
6.8
DANN
Benign
0.94
DEOGEN2
Benign
0.014
T;T;T;T;.
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.63
T;.;T;.;T
M_CAP
Benign
0.0027
T
MetaRNN
Benign
0.038
T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.3
.;L;L;.;.
PhyloP100
0.34
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.020
.;N;.;.;.
REVEL
Benign
0.024
Sift
Benign
0.38
.;T;.;.;.
Sift4G
Benign
0.28
T;T;T;T;T
Polyphen
0.043
.;B;B;.;.
Vest4
0.054
MutPred
0.35
.;Loss of sheet (P = 0.0104);Loss of sheet (P = 0.0104);.;Loss of sheet (P = 0.0104);
MVP
0.055
MPC
0.031
ClinPred
0.076
T
GERP RS
1.9
Varity_R
0.022
gMVP
0.22
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr3-16312475; API